Water Oxygenation and Brain Activity

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Muscle Damage

Treatments

Dietary Supplement: Control Unmodified Placebo Water
Dietary Supplement: Electrokinetically modified water (EMW)

Study type

Interventional

Funder types

Other

Identifiers

NCT02688452
15-00230

Details and patient eligibility

About

The primary purpose of this interventional, placebo controlled, crossover, double blind, basic science exploratory study is to investigate whether there is a difference in brain electrophysiological oscillatory activity in healthy adults before and after oral consumption of water containing very small bubbles of oxygen (electrokinetically modified water).

Enrollment

40 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men or women of any ethnic background;
  • living in New York tri-state area;
  • fluent in English;
  • normal or corrected to normal vision and hearing;
  • willing to complete all study procedures; and
  • capable of giving written informed consent.

Exclusion criteria

  • A history of gross brain abnormalities such as stroke, severe ventriculomegaly or severe periventricular white matter abnormalities;
  • a history of serious psychiatric or neurological disorders, including psychosis or major depression, alcohol or drug abuse, brain injury, seizure disorder, brain tumor, etc.;
  • taking psychoactive medications, including antipsychotics, anxiolytics and antidepressants, or cognitive enhancers such as cholinesterase inhibitors;
  • presence of contraindications for MEG or MRI recording, including any of the following: cardiac pacemaker, intracranial clips, metal implants, or external clips within 10 mm of the head, metal in eyes, claustrophobia, obesity and/or any other reason leading to difficulty staying in the MEG or MRI for up to one hour.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

40 participants in 2 patient groups

Group 1
Active Comparator group
Description:
Young Healthy Adults
Treatment:
Dietary Supplement: Electrokinetically modified water (EMW)
Dietary Supplement: Electrokinetically modified water (EMW)
Dietary Supplement: Control Unmodified Placebo Water
Group 2
Active Comparator group
Description:
Young Healthy Adults
Treatment:
Dietary Supplement: Electrokinetically modified water (EMW)
Dietary Supplement: Electrokinetically modified water (EMW)
Dietary Supplement: Control Unmodified Placebo Water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems